Annual Total Expenses
$14.37 M
-$14.11 M-49.55%
December 31, 2023
Summary
- As of February 8, 2025, FRTX annual total expenses is $14.37 million, with the most recent change of -$14.11 million (-49.55%) on December 31, 2023.
- During the last 3 years, FRTX annual total expenses has fallen by -$8.43 million (-36.99%).
- FRTX annual total expenses is now -68.62% below its all-time high of $45.77 million, reached on December 1, 2007.
Performance
FRTX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$1.65 M
-$4.29 M-72.22%
December 31, 2023
Summary
- As of February 8, 2025, FRTX quarterly total expenses is $1.65 million, with the most recent change of -$4.29 million (-72.22%) on December 31, 2023.
- Over the past year, FRTX quarterly total expenses has dropped by -$4.29 million (-72.22%).
- FRTX quarterly total expenses is now -87.93% below its all-time high of $13.69 million, reached on September 1, 2002.
Performance
FRTX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
FRTX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.5% | -72.2% |
| 3 y3 years | -37.0% | -72.2% |
| 5 y5 years | -32.5% | -72.2% |
FRTX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.7% | at low | -82.6% | at low |
| 5 y | 5-year | -64.7% | at low | -87.8% | at low |
| alltime | all time | -68.6% | +299.1% | -87.9% | at low |
Fresh Tracks Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $14.37 M(-49.6%) | $1.65 M(-72.2%) |
| Sep 2023 | - | $5.95 M(+146.0%) |
| Jun 2023 | - | $2.42 M(-44.4%) |
| Mar 2023 | - | $4.35 M(-34.5%) |
| Dec 2022 | $28.48 M(-29.9%) | $6.64 M(+1.2%) |
| Sep 2022 | - | $6.56 M(+13.7%) |
| Jun 2022 | - | $5.77 M(-39.2%) |
| Mar 2022 | - | $9.50 M(+48.2%) |
| Dec 2021 | $40.65 M(+78.3%) | - |
| Dec 2021 | - | $6.41 M(-52.5%) |
| Sep 2021 | - | $13.49 M(+15.0%) |
| Jun 2021 | - | $11.73 M(+30.0%) |
| Mar 2021 | - | $9.02 M(+21.4%) |
| Dec 2020 | $22.80 M(-29.6%) | $7.43 M(+65.4%) |
| Sep 2020 | - | $4.49 M(-21.6%) |
| Jun 2020 | - | $5.73 M(+11.4%) |
| Mar 2020 | - | $5.14 M(-55.3%) |
| Dec 2019 | $32.38 M(+52.3%) | $11.51 M(+59.0%) |
| Sep 2019 | - | $7.24 M(+141.2%) |
| Jun 2019 | - | $3.00 M(-62.9%) |
| Mar 2019 | - | $8.09 M(+98.4%) |
| Dec 2018 | $21.27 M(-21.8%) | $4.08 M(-0.9%) |
| Sep 2018 | - | $4.11 M(-29.8%) |
| Jun 2018 | - | $5.86 M(-18.8%) |
| Mar 2018 | - | $7.22 M(-7.9%) |
| Dec 2017 | $27.20 M(+14.8%) | $7.83 M(+22.0%) |
| Sep 2017 | - | $6.42 M(-6.0%) |
| Jun 2017 | - | $6.83 M(+11.7%) |
| Mar 2017 | - | $6.12 M(+3.0%) |
| Dec 2016 | $23.71 M(-21.9%) | $5.94 M(+13.9%) |
| Sep 2016 | - | $5.21 M(-4.2%) |
| Jun 2016 | - | $5.44 M(-23.5%) |
| Mar 2016 | - | $7.11 M(-23.0%) |
| Dec 2015 | $30.35 M(-4.7%) | $9.23 M(+72.6%) |
| Sep 2015 | - | $5.35 M(-23.2%) |
| Jun 2015 | - | $6.97 M(-20.8%) |
| Mar 2015 | - | $8.80 M(-7.4%) |
| Dec 2014 | $31.84 M(-18.5%) | $9.51 M(+21.3%) |
| Sep 2014 | - | $7.84 M(-8.5%) |
| Jun 2014 | - | $8.57 M(+44.5%) |
| Mar 2014 | - | $5.93 M(+10.5%) |
| Dec 2013 | $39.07 M(-4.6%) | $5.37 M(-53.4%) |
| Sep 2013 | - | $11.52 M(+2.0%) |
| Jun 2013 | - | $11.30 M(+3.8%) |
| Mar 2013 | - | $10.88 M(+10.0%) |
| Dec 2012 | $40.95 M(+8.2%) | $9.89 M(-0.6%) |
| Sep 2012 | - | $9.96 M(+4.8%) |
| Jun 2012 | - | $9.50 M(-18.1%) |
| Mar 2012 | - | $11.60 M(+29.2%) |
| Dec 2011 | $37.84 M(-5.2%) | $8.98 M(-12.2%) |
| Sep 2011 | - | $10.23 M(+10.3%) |
| Jun 2011 | - | $9.27 M(-1.0%) |
| Mar 2011 | - | $9.37 M(-8.1%) |
| Dec 2010 | $39.93 M(-3.3%) | $10.19 M(+12.4%) |
| Sep 2010 | - | $9.07 M(-14.3%) |
| Jun 2010 | - | $10.58 M(+4.8%) |
| Mar 2010 | - | $10.09 M(+1.2%) |
| Dec 2009 | $41.27 M(-8.9%) | $9.97 M(-9.0%) |
| Sep 2009 | - | $10.95 M(+11.9%) |
| Jun 2009 | - | $9.79 M(-7.4%) |
| Mar 2009 | - | $10.57 M(-2.2%) |
| Dec 2008 | $45.30 M | $10.80 M(-2.0%) |
| Sep 2008 | - | $11.03 M(-3.5%) |
| Jun 2008 | - | $11.43 M(-5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $12.04 M(+13.5%) |
| Dec 2007 | $45.77 M(+11.2%) | $10.60 M(-0.4%) |
| Sep 2007 | - | $10.64 M(-14.3%) |
| Jun 2007 | - | $12.41 M(+2.5%) |
| Mar 2007 | - | $12.12 M(+14.3%) |
| Dec 2006 | $41.16 M(+9.3%) | $10.60 M(+19.9%) |
| Sep 2006 | - | $8.84 M(-20.2%) |
| Jun 2006 | - | $11.08 M(+4.1%) |
| Mar 2006 | - | $10.64 M(+32.9%) |
| Dec 2005 | $37.65 M(-5.1%) | $8.01 M(-12.2%) |
| Sep 2005 | - | $9.12 M(-9.1%) |
| Jun 2005 | - | $10.03 M(-4.5%) |
| Mar 2005 | - | $10.50 M(+7.7%) |
| Dec 2004 | $39.69 M(+16.1%) | $9.75 M(+13.0%) |
| Sep 2004 | - | $8.63 M(-22.9%) |
| Jun 2004 | - | $11.19 M(+10.6%) |
| Mar 2004 | - | $10.12 M(+14.4%) |
| Dec 2003 | $34.18 M(-11.5%) | $8.85 M(+2.1%) |
| Sep 2003 | - | $8.66 M(+7.3%) |
| Jun 2003 | - | $8.07 M(-6.2%) |
| Mar 2003 | - | $8.61 M(-2.2%) |
| Dec 2002 | $38.63 M(+35.1%) | $8.80 M(-35.7%) |
| Sep 2002 | - | $13.69 M(+62.6%) |
| Jun 2002 | - | $8.42 M(+9.1%) |
| Mar 2002 | - | $7.72 M(+2.5%) |
| Dec 2001 | $28.60 M(+20.3%) | $7.53 M(+9.1%) |
| Sep 2001 | - | $6.90 M(-4.0%) |
| Jun 2001 | - | $7.19 M(+3.2%) |
| Mar 2001 | - | $6.97 M(+10.2%) |
| Dec 2000 | $23.78 M(+20.7%) | $6.32 M(+9.3%) |
| Sep 2000 | - | $5.79 M(-3.9%) |
| Jun 2000 | - | $6.02 M(+6.6%) |
| Mar 2000 | - | $5.65 M(+0.8%) |
| Dec 1999 | $19.70 M(+25.5%) | $5.60 M(+21.7%) |
| Sep 1999 | - | $4.60 M(-4.2%) |
| Jun 1999 | - | $4.80 M(+4.3%) |
| Mar 1999 | - | $4.60 M(+27.8%) |
| Dec 1998 | $15.70 M(+0.6%) | $3.60 M(-12.2%) |
| Sep 1998 | - | $4.10 M(0.0%) |
| Jun 1998 | - | $4.10 M(0.0%) |
| Mar 1998 | - | $4.10 M(+2.5%) |
| Dec 1997 | $15.60 M(+7.6%) | $4.00 M(-4.8%) |
| Sep 1997 | - | $4.20 M(+13.5%) |
| Jun 1997 | - | $3.70 M(0.0%) |
| Mar 1997 | - | $3.70 M(-11.9%) |
| Dec 1996 | $14.50 M(+21.8%) | $4.20 M(+23.5%) |
| Sep 1996 | - | $3.40 M(-10.5%) |
| Jun 1996 | - | $3.80 M(+22.6%) |
| Mar 1996 | - | $3.10 M(+10.7%) |
| Dec 1995 | $11.90 M(+9.2%) | $2.80 M(+12.0%) |
| Sep 1995 | - | $2.50 M(-34.2%) |
| Jun 1995 | - | $3.80 M(+35.7%) |
| Mar 1995 | - | $2.80 M(0.0%) |
| Dec 1994 | $10.90 M(+34.6%) | $2.80 M(+3.7%) |
| Sep 1994 | - | $2.70 M(-6.9%) |
| Jun 1994 | - | $2.90 M(+11.5%) |
| Mar 1994 | - | $2.60 M(+18.2%) |
| Dec 1993 | $8.10 M(+39.7%) | $2.20 M(+10.0%) |
| Sep 1993 | - | $2.00 M(-4.8%) |
| Jun 1993 | - | $2.10 M(+16.7%) |
| Mar 1993 | - | $1.80 M |
| Dec 1992 | $5.80 M(+23.4%) | - |
| Dec 1991 | $4.70 M(+30.6%) | - |
| Dec 1990 | $3.60 M | - |
FAQ
- What is Fresh Tracks Therapeutics annual total expenses?
- What is the all time high annual total expenses for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics annual total expenses year-on-year change?
- What is Fresh Tracks Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly total expenses year-on-year change?
What is Fresh Tracks Therapeutics annual total expenses?
The current annual total expenses of FRTX is $14.37 M
What is the all time high annual total expenses for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual total expenses is $45.77 M
What is Fresh Tracks Therapeutics annual total expenses year-on-year change?
Over the past year, FRTX annual total expenses has changed by -$14.11 M (-49.55%)
What is Fresh Tracks Therapeutics quarterly total expenses?
The current quarterly total expenses of FRTX is $1.65 M
What is the all time high quarterly total expenses for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly total expenses is $13.69 M
What is Fresh Tracks Therapeutics quarterly total expenses year-on-year change?
Over the past year, FRTX quarterly total expenses has changed by -$4.29 M (-72.22%)